Prostatic Neoplasms: all 6,484 studies
Page 30 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Real-Life Pilot Feasibility Study (LC_RLP)CompletedNCT05797727Not applicable
- A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsActive, not recruitingNCT05787587Phase 1
- ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology TreatmentStatus unknownNCT05787145Not applicable
- Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate CancerCompletedNCT05773703Early Phase 1
- Validating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard QuestionnairesCompletedNCT05772598
- Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPCWithdrawnNCT05771896Phase 3
- Comparison of Outcomes of Multiple Platforms for Assisted Robotic - ProstateStatus unknownNCT05766163Not applicable
- Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active SurveillanceCompletedNCT05764330Not applicable
- Comparing Water Vapour Thermal Therapy (Rezūm) and TURPCompletedNCT05762198Not applicable
- Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate BiopsyActive, not recruitingNCT05761912
- Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice ExperimentCompletedNCT05761093
- A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in ItalyCompletedNCT05759273
- PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care InterventionCompletedNCT05755490Not applicable
- African Cancer Genome: GMDCompletedNCT05754658
- Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate CancerActive, not recruitingNCT05751941Phase 2
- Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical ProstatectomyActive, not recruitingNCT05746806Not applicable
- Evaluation of Neuromuscular ElectroStimulation in Addition to a Physical Activity ProgramTerminatedNCT05745844Not applicable
- Ga-68-PSMA-11 in Men With Prostate CancerTerminatedNCT05744115Phase 3
- Evaluating Return to Continence and Potency Following Radical ProstatectomyWithdrawnNCT05742334Not applicable
- Effects of Prostate Cancer on Brain FunctionStatus unknownNCT05737004
- Ultrasound for Detection of Prostate CancerCompletedNCT05736094Not applicable
- Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate CancerTerminatedNCT05733351Phase 1
- PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate CancerStatus unknownNCT05732948Phase 1
- Phase 0/1 Study of 212Pb-NG001 in mCRPCCompletedNCT05725070Early Phase 1
- Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PETActive, not recruitingNCT05722925Phase 4
- Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal CancersActive, not recruitingNCT05722288Phase 2
- Streamlined Geriatric and Oncological Evaluation Based On IC TechnologyActive, not recruitingNCT05720910Not applicable
- Feasibility of Technology-Based SSIP in Prostate Cancer PatientsActive, not recruitingNCT05720832Not applicable
- APalutamiAPalutamide and stEReotactic Body Radiation Therapy for Metastatic Prostate CancerStatus unknownNCT05717660Phase 2
- An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate CancerActive, not recruitingNCT05712473
- A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate CancerTerminatedNCT05712174Phase 2
- MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted BiopsyActive, not recruitingNCT05710380Not applicable
- PSMA-PET/CT RegistryTerminatedNCT05709535
- A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)CompletedNCT05708950Phase 1/2
- 18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot StudyWithdrawnNCT05707182Early Phase 1
- Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate CancerActive, not recruitingNCT05705921Not applicable
- Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)WithdrawnNCT05705700Phase 2
- Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)Status unknownNCT05702619
- MyProstateScore Equivalency With and Without DREStatus unknownNCT05700370Not applicable
- Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate CancerStatus unknownNCT05690399
- CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene MutationsTerminatedNCT05689021Phase 2
- Androgen Receptor Signaling and Prostate-Specific Membrane Antigen ExpressionActive, not recruitingNCT05683964Early Phase 1
- Water Vapor Ablation for Localized Intermediate Risk Prostate CancerActive, not recruitingNCT05683691Not applicable
- A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer PatientsTerminatedNCT05679388Phase 1
- Perioperative Propranolol During Prostatectomy to Decrease Cancer RecurrenceCompletedNCT05679193Phase 2
- MRI Guided Radiation Therapy for the Treatment of High Risk Prostate CancerTerminatedNCT05676463Phase 2
- A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC PatientsActive, not recruitingNCT05676203Phase 3
- A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate CancerTerminatedNCT05673109Phase 1
- Implementation of a Multimodal Prehabilitation Program in Robotic Oncological SurgeryCompletedNCT05671094Not applicable
- a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without BiopsyStatus unknownNCT05670691
- Stereotactic Ablative Radiation Therapy for Prostate CancerActive, not recruitingNCT05668351Not applicable
- Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RPStatus unknownNCT05667636Phase 2
- Checkpoint Inhibitors and SBRT for MCRPCCompletedNCT05655715Phase 2
- ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate CancerActive, not recruitingNCT05653063
- Rectal Spacer for Prostate Cancer Radiation Image GuidanceCompletedNCT05650021Not applicable
- HRQOL in Prostate Cancer Patients Treated With RadiotherapyActive, not recruitingNCT05645237
- Influence of Electronic Patient Reported Outcomes (ePROMs) in Surgical Therapy for Prostate Cancer on Postoperative OutcomeCompletedNCT05644821Not applicable
- 64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)TerminatedNCT05633160Phase 1/2
- Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate CancerStatus unknownNCT05631080Phase 4
- 68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone MetastasisStatus unknownNCT05627778Phase 1/2
- 68Ga-labeled NY108 PET Imaging in PatientsStatus unknownNCT05623878Early Phase 1
- Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7Active, not recruitingNCT05622162Phase 3
- PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online MRgRTCompletedNCT05615909
- Symptom Management, Education and Telephone Follow-up, Quality of Life,CompletedNCT05613881Not applicable
- Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP)CompletedNCT05613842Phase 2
- Physical Function During ARSI TreatmentCompletedNCT05612880
- A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Life SettingStatus unknownNCT05612841
- Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory StudyCompletedNCT05612204Not applicable
- Prehabilitation in Prostate Cancer Patients, TelePrehabTrialActive, not recruitingNCT05608746Not applicable
- A Study of [225Ac]-FPI-2059 in Adult Participants With Solid TumoursTerminatedNCT05605522Phase 1
- Posterior Urethrovesical Anastomotic Reconstruction in Comparison to Conventional Urethrovesical AnastomosisCompletedNCT05605171Not applicable
- Opioid-Free Pain Control Regimen Following Robotic Radical ProstatectomyTerminatedNCT05597878Phase 2/3
- Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy.Status unknownNCT05596851
- Prospective Comparison of the Four Biopsy Methods for Prostate Cancer DetectionCompletedNCT05589558Not applicable
- Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic ModelActive, not recruitingNCT05587192Not applicable
- Sleep Hygiene Education, ReadiWatchTM Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia Effect, on Symptom Relief for Men With Prostate Cancer Receiving Androgen Deprivation TherapyCompletedNCT05582759Not applicable
- Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable CancersWithdrawnNCT05582031Phase 2
- [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2Active, not recruitingNCT05579184Phase 2
- A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate CancerWithdrawnNCT05574712Phase 2
- Tumor Molecular Profiling in Patients With Prostate CancerCompletedNCT05573789
- ExoDx Prostate Evaluation in Active Surveillance Patient PopulationStatus unknownNCT05572099
- Prostate MRI and Pylarify PSMA PET/CTWithdrawnNCT05568537Phase 4
- ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcerWithdrawnNCT05567770Phase 1
- A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate CancerWithdrawnNCT05567679Early Phase 1
- The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic ProstatectomyCompletedNCT05566405Not applicable
- Total Body PET-CT Imaging of Prostate Cancer Using IlluccixStatus unknownNCT05558956Early Phase 1
- Contribution of Canine Detection in the Diagnostic Strategy of High-risk Prostate Cancer (Prostate-K9-Detect)CompletedNCT05558735
- Micro-UltraSound In Cancer - Active SurveillanceActive, not recruitingNCT05558241Not applicable
- HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate CancerTerminatedNCT05553639Phase 1/2
- Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.CompletedNCT05553327Not applicable
- Polaprezinc Treatment for Enzalutamide- or Abiraterone-resistant CRPCCompletedNCT05549778Phase 1/2
- A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard TherapyCompletedNCT05547061Phase 1/2
- Study of Oral MRT-2359 in Selected Cancer PatientsActive, not recruitingNCT05546268Phase 1/2
- A Study of Cognitive Health in Survivors of Prostate CancerActive, not recruitingNCT05540782
- An Acupuncture Study for Prostate Cancer Survivors With Urinary IssuesActive, not recruitingNCT05540392Phase 1/2
- Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of CancerCompletedNCT05533515
- Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)Status unknownNCT05533203Phase 1
- Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer PatientsCompletedNCT05527483
- Clinical Utility Study for MyProstateScore+CompletedNCT05525806Not applicable
- New Treatment Modalities for Localized Prostate CancerActive, not recruitingNCT05523856